Abstract

Systemic sclerosis (SSc) is a multisystem autoimmune and vascular disease resulting in fibrosis of various organs with unknown etiology. Accumulating evidence suggests that a common pathologic cascade across multiple organs and additional organ-specific pathologies underpin SSc development. The common pathologic cascade starts with vascular injury due to autoimmune attacks and unknown environmental factors. After that, dysregulated angiogenesis and defective vasculogenesis promote vascular structural abnormalities, such as capillary loss and arteriolar stenosis, while aberrantly activated endothelial cells facilitate the infiltration of circulating immune cells into perivascular areas of various organs. Arteriolar stenosis directly causes pulmonary arterial hypertension, scleroderma renal crisis and digital ulcers. Chronic inflammation persistently activates interstitial fibroblasts, leading to the irreversible fibrosis of multiple organs. The common pathologic cascade interacts with a variety of modifying factors in each organ, such as keratinocytes and adipocytes in the skin, esophageal stratified squamous epithelia and myenteric nerve system in gastrointestinal tract, vasospasm of arterioles in the heart and kidney, and microaspiration of gastric content in the lung. To better understand SSc pathogenesis and develop new disease-modifying therapies, it is quite important to understand the complex pathogenesis of SSc from the two distinct perspectives, namely the common pathologic cascade and additional organ-specific pathologies.

Highlights

  • Systemic sclerosis (SSc) is a multisystem connective tissue disease with unknown etiology, characterized by aberrant immune activation, vascular injury followed by defective neovascularization and impaired vessel remodeling, and resultant tissue fibrosis of the skin and various internal organs [1,2,3]

  • SSc presents with a variety of clinical symptoms, including skin sclerosis, digital ulcers, interstitial lung disease (ILD), pulmonary hypertension (PH), cardiac fibrosis, gastrointestinal (GI) involvement, liver dysfunction and scleroderma renal crisis (SRC), all of which are caused by a common disease-specific pathologic cascade across multiple organs and additional organ-specific pathologies

  • The functional abnormalities include endothelial dysfunction, primarily due to the low availability of nitric oxide (NO), the altered expression of cell adhesion molecules inducing the infiltration of Th2 and Th17 cells, mast cells and macrophages, the activated endothelial-to-mesenchymal transition (EndoMT) leading to fibro-proliferative vascular change and tissue fibrosis, the impairing of the coagulation/fibrinolysis system promoting the formation of intravascular fibrin deposits, and the excessive production of reactive oxygen species (ROS)

Read more

Summary

Introduction

Systemic sclerosis (SSc) is a multisystem connective tissue disease with unknown etiology, characterized by aberrant immune activation, vascular injury followed by defective neovascularization and impaired vessel remodeling, and resultant tissue fibrosis of the skin and various internal organs [1,2,3]. SSc presents with a variety of clinical symptoms, including skin sclerosis, digital ulcers, interstitial lung disease (ILD), pulmonary hypertension (PH), cardiac fibrosis, gastrointestinal (GI) involvement, liver dysfunction and scleroderma renal crisis (SRC), all of which are caused by a common disease-specific pathologic cascade across multiple organs and additional organ-specific pathologies. In terms of the management of SSc, it is quite important to understand “the common pathologic cascade across multiple organs” and “the additional organ-specific pathologies” separately. This article overviews the understanding of SSc pathogenesis based on these two distinct aspects

The Common SSc-Specific Pathologic Cascade across Multiple Organs
Genetic Factors and Environmental Influences
Aberrant Vascular Reaction to Initial Vascular Injury
Inflammation
The Activation of Fibroblasts
The Role of Agonistic Autoantibodies
Keratinocytes
Adipocytes
GI Involvement
Lung Involvement
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call